Cidara Therapeutics Inc (CDTX)
12.76
-0.33
(-2.52%)
USD |
NASDAQ |
May 15, 14:34
Cidara Therapeutics Total Liabilities (Quarterly): 75.24M for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 75.24M |
| September 30, 2023 | 55.43M |
| June 30, 2023 | 52.57M |
| March 31, 2023 | 54.90M |
| December 31, 2022 | 61.92M |
| September 30, 2022 | 57.79M |
| June 30, 2022 | 47.48M |
| March 31, 2022 | 50.34M |
| December 31, 2021 | 53.75M |
| September 30, 2021 | 52.36M |
| June 30, 2021 | 47.96M |
| March 31, 2021 | 52.32M |
| December 31, 2020 | 49.71M |
| September 30, 2020 | 34.12M |
| June 30, 2020 | 32.05M |
| March 31, 2020 | 30.34M |
| December 31, 2019 | 31.14M |
| September 30, 2019 | 32.73M |
| June 30, 2019 | 19.97M |
| Date | Value |
|---|---|
| March 31, 2019 | 20.45M |
| December 31, 2018 | 19.97M |
| September 30, 2018 | 22.88M |
| June 30, 2018 | 24.87M |
| March 31, 2018 | 19.33M |
| December 31, 2017 | 19.29M |
| September 30, 2017 | 16.86M |
| June 30, 2017 | 19.89M |
| March 31, 2017 | 16.77M |
| December 31, 2016 | 18.78M |
| September 30, 2016 | 8.317M |
| June 30, 2016 | 5.215M |
| March 31, 2016 | 4.145M |
| December 31, 2015 | 6.062M |
| September 30, 2015 | 4.363M |
| June 30, 2015 | 3.096M |
| March 31, 2015 | 78.31M |
| December 31, 2014 | 35.80M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
19.97M
Minimum
Jun 2019
75.24M
Maximum
Dec 2023
46.95M
Average
50.34M
Median
Mar 2022
Total Liabilities (Quarterly) Benchmarks
| Johnson & Johnson | 101.95B |
| NovaBay Pharmaceuticals Inc | 5.197M |
| Palatin Technologies Inc | 24.94M |
| iBio Inc | 24.82M |
| Theriva Biologics Inc | 14.61M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 67.03M |
| Shareholders Equity (Quarterly) | -8.21M |
| Current Ratio | 0.9027 |